Genomma Lab Internacional, S.A.B. de C.V.

BMV:LAB B Rapporto sulle azioni

Cap. di mercato: Mex$17.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Genomma Lab Internacional. de Dividendo

Dividendo criteri di controllo 3/6

Genomma Lab Internacional. de è una società che paga dividendi con un rendimento attuale pari a 4.12%, ben coperto dagli utili.

Informazioni chiave

4.3%

Rendimento del dividendo

28%

Rapporto di remunerazione

Rendimento medio del settore2.1%
Prossima data di pagamento dei dividendin/a
Data di stacco del dividendon/a
Dividendo per azioneMex$0.800
Utile per azioneMex$1.39
Previsione del rendimento del dividendo a 3 anni1.8%

Aggiornamenti recenti sui dividendi

Recent updates

With Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) It Looks Like You'll Get What You Pay For

Jul 12
With Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) It Looks Like You'll Get What You Pay For

These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well

May 31
These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well

Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Jan 29
Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 49% Discount?

Nov 07
Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 49% Discount?

Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?

Mar 31
Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?

Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 32% Discount?

Feb 24
Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 32% Discount?

Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?

Dec 07
Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?

Rainbows and Unicorns: Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Analysts Just Became A Lot More Optimistic

Sep 24
Rainbows and Unicorns: Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Analysts Just Became A Lot More Optimistic

Analysts Just Made A Major Revision To Their Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Revenue Forecasts

Aug 01
Analysts Just Made A Major Revision To Their Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Revenue Forecasts

Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Jul 27
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Mar 22
Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?

Feb 15
Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?

Genomma Lab Internacional. de (BMV:LABB) Seems To Use Debt Quite Sensibly

Nov 24
Genomma Lab Internacional. de (BMV:LABB) Seems To Use Debt Quite Sensibly

Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock

Sep 08
Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock

Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Intrinsic Value Is Potentially 96% Above Its Share Price

Jun 10
Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Intrinsic Value Is Potentially 96% Above Its Share Price

Is Genomma Lab Internacional. de (BMV:LABB) A Risky Investment?

May 24
Is Genomma Lab Internacional. de (BMV:LABB) A Risky Investment?

Should You Be Adding Genomma Lab Internacional. de (BMV:LABB) To Your Watchlist Today?

May 06
Should You Be Adding Genomma Lab Internacional. de (BMV:LABB) To Your Watchlist Today?

Investors Who Bought Genomma Lab Internacional. de (BMV:LABB) Shares Five Years Ago Are Now Up 65%

Mar 13
Investors Who Bought Genomma Lab Internacional. de (BMV:LABB) Shares Five Years Ago Are Now Up 65%

Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Feb 19
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Do Its Financials Have Any Role To Play In Driving Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Stock Up Recently?

Feb 02
Do Its Financials Have Any Role To Play In Driving Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Stock Up Recently?

Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 42%?

Jan 15
Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 42%?

What Is The Ownership Structure Like For Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)?

Dec 28
What Is The Ownership Structure Like For Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)?

Genomma Lab Internacional. de (BMV:LABB) Shareholders Have Enjoyed A 54% Share Price Gain

Dec 10
Genomma Lab Internacional. de (BMV:LABB) Shareholders Have Enjoyed A 54% Share Price Gain

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Sebbene i pagamenti dei dividendi siano rimasti stabili, LAB B paga dividendi da meno di 10 anni.

Dividendo in crescita: I pagamenti dei dividendi di LAB B sono aumentati, ma la società ha pagato dividendi solo per 3 anni.


Rendimento dei dividendi rispetto al mercato

Genomma Lab Internacional. de Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di LAB B rispetto al mercato?
SegmentoRendimento dei dividendi
Azienda (LAB B)4.3%
Fondo del 25% del mercato (MX)2.2%
Top 25% del mercato (MX)7.2%
Media del settore (Pharmaceuticals)2.1%
Previsione dell'analista in 3 anni (LAB B)1.8%

Dividendo notevole: Il dividendo di LAB B ( 4.04% ) è più alto rispetto al 25% inferiore dei pagatori di dividendi nel mercato MX ( 2.1% ).

Dividendo elevato: Il dividendo di LAB B ( 4.12% ) è basso rispetto al 25% dei maggiori pagatori di dividendi nel mercato MX ( 7.2%.


Distribuzione degli utili agli azionisti

Copertura degli utili: Grazie al suo payout ratio ( 28.4% ) ragionevolmente basso, i pagamenti dei dividendi di LAB B sono ben coperti dagli utili.


Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Grazie al suo ragionevole cash payout ratio ( 52.4% ), i pagamenti dei dividendi di LAB B sono coperti dai flussi di cassa.


Scoprire le società che pagano dividendi forti